Megan Pullein

Megan Pullein is a Senior Scientist at Healx, where responsibilities include conducting high content screening and generating large omics datasets for integration into Healx's proprietary knowledge graph and AI/ML interrogation, as well as assay development and cell biology for pre-clinical rare disease research programs. Previous roles include Scientist at Healx, focusing on cell biology and assay development for rare diseases, and Scientist at Wren Therapeutics Ltd, specializing in innovative assay design for transient oligomer targets linked to protein misfolding diseases. At AstraZeneca, Megan held positions as a Scientist and Research Scientist degree apprentice, concentrating on assay development and screening of biologics, as well as antibody discovery and protein engineering. Megan began their career as a QC Microbiologist apprentice at Thermo Fisher Scientific, where microbiology laboratory techniques were employed to ensure product quality following regulatory guidelines. Megan holds a Bachelor of Science degree in Applied Biosciences from the University of Kent.